Peptide Nucleic Acid-Based Biosensors for Cancer Diagnosis
Open Access
- 11 November 2017
- Vol. 22 (11), 1951
- https://doi.org/10.3390/molecules22111951
Abstract
The monitoring of DNA and RNA biomarkers freely circulating in the blood constitutes the basis of innovative cancer detection methods based on liquid biopsy. Such methods are expected to provide new opportunities for a better understanding of cancer disease at the molecular level, thus contributing to improved patient outcomes. Advanced biosensors can advance possibilities for cancer-related nucleic acid biomarkers detection. In this context, peptide nucleic acids (PNAs) play an important role in the fabrication of highly sensitive biosensors. This review provides an overview of recently described PNA-based biosensors for cancer biomarker detection. One of the most striking features of the described detection approaches is represented by the possibility to detect target nucleic acids at the ultra-low concentration with the capability to identify single-base mutations.Funding Information
- Horizon 2020 Framework Programme (633937)
This publication has 127 references indexed in Scilit:
- Reactivity mapping with electrochemical gradients for monitoring reactivity at surfaces in space and timeNature Communications, 2013
- Isothermal Amplification Methods for the Detection of Nucleic Acids in Microfluidic DevicesBiosensors, 2012
- Detection of Chromosomal Alterations in the Circulation of Cancer Patients with Whole-Genome SequencingScience Translational Medicine, 2012
- Detecting KRAS mutations in peripheral blood of colorectal cancer patients by peptide nucleic acid clamp PCRExperimental and Therapeutic Medicine, 2012
- The Genetic Basis for Cancer Treatment DecisionsCell, 2012
- High-sensitivity nanosensors for biomarker detectionChemical Society Reviews, 2011
- From Cleanroom to Desktop: Emerging Micro-Nanofabrication Technology for Biomedical ApplicationsAnnals of Biomedical Engineering, 2010
- An Analysis of Human MicroRNA and Disease AssociationsPLOS ONE, 2008
- MicroRNA expression profiles classify human cancersNature, 2005
- c-Myc-regulated microRNAs modulate E2F1 expressionNature, 2005